Methyl-n-amylnitrosamine
Methyl-n-amylnitrosamine (MNAN) is a potential carcinogen[1] It is metabolized in the liver by the enzyme CYP2A6.
 | |
| Names | |
|---|---|
| Preferred IUPAC name
N-Methyl-N-pentylnitrous amide | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| MeSH | N-amyl-N-methylnitrosamine |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C6H14N2O | |
| Molar mass | 130.191 g·mol−1 |
| Appearance | Yellow, transparent liquid |
| log P | 1.542 |
| Related compounds | |
Related amines |
|
Related compounds |
Agmatine |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
 verify (what is  ?) | |
| Infobox references | |
References
- Bulay O, Mirvish SS (September 1979). "Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine". Cancer Res. 39 (9): 3644–6. PMID 476689.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.